{"entity":{"type":"insider","cik":"0001325710","url":"/insider/0001325710","json_url":"/insider/0001325710.json","name":"Sherman Matthew L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":126,"n_filings":49,"first":"2014-04-24","last":"2024-02-20","span_basis":"filed_date"},"name_variants":[{"name":"Sherman Matthew L","source":"filing","n_filings":49,"first_seen":"2014-04-24","last_seen":"2024-02-20"}],"transactions":[{"id":2824490,"accession":"0000950170-24-017085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-017085","line_url":"/filing/0000950170-24-017085#line-2","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2615.0,"shares_display":"2,615","price_per_share":15.6177,"price_display":"15.62","price_state":"stated","total_value":40840.2855,"total_display":"40,840.29","shares_owned_after":108739.0,"shares_owned_after_display":"108,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-20","scope":"insider"},{"id":2892272,"accession":"0000950170-24-005393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-005393","line_url":"/filing/0000950170-24-005393#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2435.0,"shares_display":"2,435","price_per_share":14.4697,"price_display":"14.47","price_state":"stated","total_value":35233.7195,"total_display":"35,233.72","shares_owned_after":94079.0,"shares_owned_after_display":"94,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8750146,"accession":"0000950170-23-070382","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-070382","line_url":"/filing/0000950170-23-070382#line-2","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2792.0,"shares_display":"2,792","price_per_share":15.3671,"price_display":"15.37","price_state":"stated","total_value":42904.9432,"total_display":"42,904.94","shares_owned_after":96514.0,"shares_owned_after_display":"96,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-14","scope":"insider"},{"id":8023576,"accession":"0001209191-23-053939","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-053939","line_url":"/filing/0001209191-23-053939#line-2","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2360.0,"shares_display":"2,360","price_per_share":12.0176,"price_display":"12.02","price_state":"stated","total_value":28361.536,"total_display":"28,361.54","shares_owned_after":90628.0,"shares_owned_after_display":"90,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-30","filed_date":"2023-10-31","scope":"insider"},{"id":7836650,"accession":"0001209191-23-051886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-051886","line_url":"/filing/0001209191-23-051886#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2942.0,"shares_display":"2,942","price_per_share":12.68,"price_display":"12.68","price_state":"stated","total_value":37304.56,"total_display":"37,304.56","shares_owned_after":84744.0,"shares_owned_after_display":"84,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-04","scope":"insider"},{"id":8372436,"accession":"0001209191-23-038756","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038756","line_url":"/filing/0001209191-23-038756#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1655.0,"shares_display":"1,655","price_per_share":14.4018,"price_display":"14.40","price_state":"stated","total_value":23834.979,"total_display":"23,834.98","shares_owned_after":87686.0,"shares_owned_after_display":"87,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-21","scope":"insider"},{"id":8651376,"accession":"0001209191-23-010506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-010506","line_url":"/filing/0001209191-23-010506#line-2","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":971.0,"shares_display":"971","price_per_share":15.099,"price_display":"15.10","price_state":"stated","total_value":14661.129,"total_display":"14,661.13","shares_owned_after":88145.0,"shares_owned_after_display":"88,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":7916549,"accession":"0001209191-23-003998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003998","line_url":"/filing/0001209191-23-003998#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2403.0,"shares_display":"2,403","price_per_share":21.2413,"price_display":"21.24","price_state":"stated","total_value":51042.8439,"total_display":"51,042.84","shares_owned_after":72628.0,"shares_owned_after_display":"72,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6853957,"accession":"0001209191-22-052717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052717","line_url":"/filing/0001209191-22-052717#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2587.0,"shares_display":"2,587","price_per_share":18.73,"price_display":"18.73","price_state":"stated","total_value":48454.51,"total_display":"48,454.51","shares_owned_after":74297.0,"shares_owned_after_display":"74,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6728725,"accession":"0001209191-22-038432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038432","line_url":"/filing/0001209191-22-038432#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1768.0,"shares_display":"1,768","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":19006.0,"total_display":"19,006.00","shares_owned_after":76884.0,"shares_owned_after_display":"76,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-21","scope":"insider"},{"id":6777631,"accession":"0001209191-22-011361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011361","line_url":"/filing/0001209191-22-011361#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":984.0,"shares_display":"984","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":8905.2,"total_display":"8,905.20","shares_owned_after":76790.0,"shares_owned_after_display":"76,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":5054726,"accession":"0001209191-21-059804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-059804","line_url":"/filing/0001209191-21-059804#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2659.0,"shares_display":"2,659","price_per_share":33.17,"price_display":"33.17","price_state":"stated","total_value":88199.03,"total_display":"88,199.03","shares_owned_after":46029.0,"shares_owned_after_display":"46,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-06","scope":"insider"},{"id":4554186,"accession":"0001209191-21-012114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-012114","line_url":"/filing/0001209191-21-012114#line-2","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132.0,"shares_display":"132","price_per_share":48.87,"price_display":"48.87","price_state":"stated","total_value":6450.84,"total_display":"6,450.84","shares_owned_after":37286.0,"shares_owned_after_display":"37,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":6677854,"accession":"0000899243-18-009608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-009608","line_url":"/filing/0000899243-18-009608#line-1","is_derivative":false,"issuer_cik":"0001325710","issuer_name":"Pulmatrix, Inc.","issuer_ticker":"PULM","issuer_name_source":null,"issuer_url":"/issuer/0001325710","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-03","filed_date":"2018-04-05","scope":"insider"},{"id":6136353,"accession":"0001179110-18-005397","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-005397","line_url":"/filing/0001179110-18-005397#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":38.28,"price_display":"38.28","price_state":"stated","total_value":141636.0,"total_display":"141,636.00","shares_owned_after":69667.0,"shares_owned_after_display":"69,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-03","filed_date":"2018-04-04","scope":"insider"},{"id":6136350,"accession":"0001179110-18-005397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-005397","line_url":"/filing/0001179110-18-005397#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":39.04,"price_display":"39.04","price_state":"stated","total_value":35136.0,"total_display":"35,136.00","shares_owned_after":68767.0,"shares_owned_after_display":"68,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-03","filed_date":"2018-04-04","scope":"insider"},{"id":6594308,"accession":"0001179110-18-000545","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-18-000545","line_url":"/filing/0001179110-18-000545#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":42.4,"price_display":"42.40","price_state":"stated","total_value":97520.0,"total_display":"97,520.00","shares_owned_after":75400.0,"shares_owned_after_display":"75,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-04","scope":"insider"},{"id":6594306,"accession":"0001179110-18-000545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-000545","line_url":"/filing/0001179110-18-000545#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2033.0,"shares_display":"2,033","price_per_share":43.33,"price_display":"43.33","price_state":"stated","total_value":88089.89,"total_display":"88,089.89","shares_owned_after":73367.0,"shares_owned_after_display":"73,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-04","scope":"insider"},{"id":6594304,"accession":"0001179110-18-000545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-000545","line_url":"/filing/0001179110-18-000545#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":40.86,"price_display":"40.86","price_state":"stated","total_value":12258.0,"total_display":"12,258.00","shares_owned_after":77700.0,"shares_owned_after_display":"77,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-04","scope":"insider"},{"id":5275781,"accession":"0001179110-17-012288","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-17-012288","line_url":"/filing/0001179110-17-012288#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16650.0,"shares_display":"16,650","price_per_share":38.32,"price_display":"38.32","price_state":"stated","total_value":638028.0,"total_display":"638,028.00","shares_owned_after":79750.0,"shares_owned_after_display":"79,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-12","filed_date":"2017-09-14","scope":"insider"},{"id":5275771,"accession":"0001179110-17-012288","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-012288","line_url":"/filing/0001179110-17-012288#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":39.24,"price_display":"39.24","price_state":"stated","total_value":62784.0,"total_display":"62,784.00","shares_owned_after":78150.0,"shares_owned_after_display":"78,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-12","filed_date":"2017-09-14","scope":"insider"},{"id":5275765,"accession":"0001179110-17-012288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-012288","line_url":"/filing/0001179110-17-012288#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":39.91,"price_display":"39.91","price_state":"stated","total_value":5986.5,"total_display":"5,986.50","shares_owned_after":78000.0,"shares_owned_after_display":"78,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-12","filed_date":"2017-09-14","scope":"insider"},{"id":4334256,"accession":"0001179110-17-010224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-010224","line_url":"/filing/0001179110-17-010224#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":512000.0,"total_display":"512,000.00","shares_owned_after":96400.0,"shares_owned_after_display":"96,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-07","scope":"insider"},{"id":4191634,"accession":"0001179110-17-000681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-000681","line_url":"/filing/0001179110-17-000681#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":27.62,"price_display":"27.62","price_state":"stated","total_value":44192.0,"total_display":"44,192.00","shares_owned_after":96500.0,"shares_owned_after_display":"96,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-06","scope":"insider"},{"id":4191629,"accession":"0001179110-17-000681","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-000681","line_url":"/filing/0001179110-17-000681#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":26.81,"price_display":"26.81","price_state":"stated","total_value":10724.0,"total_display":"10,724.00","shares_owned_after":98100.0,"shares_owned_after_display":"98,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-04","filed_date":"2017-01-06","scope":"insider"},{"id":3195851,"accession":"0001179110-16-027493","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-16-027493","line_url":"/filing/0001179110-16-027493#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20207.0,"shares_display":"20,207","price_per_share":34.89,"price_display":"34.89","price_state":"stated","total_value":705022.23,"total_display":"705,022.23","shares_owned_after":73604.0,"shares_owned_after_display":"73,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":3195849,"accession":"0001179110-16-027493","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-16-027493","line_url":"/filing/0001179110-16-027493#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5793.0,"shares_display":"5,793","price_per_share":34.2,"price_display":"34.20","price_state":"stated","total_value":198120.6,"total_display":"198,120.60","shares_owned_after":93811.0,"shares_owned_after_display":"93,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":2307167,"accession":"0001179110-16-022918","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-16-022918","line_url":"/filing/0001179110-16-022918#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23920.0,"shares_display":"23,920","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":765440.0,"total_display":"765,440.00","shares_owned_after":85604.0,"shares_owned_after_display":"85,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-08","scope":"insider"},{"id":2307157,"accession":"0001179110-16-022918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-16-022918","line_url":"/filing/0001179110-16-022918#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2080.0,"shares_display":"2,080","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":66560.0,"total_display":"66,560.00","shares_owned_after":95524.0,"shares_owned_after_display":"95,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-06","filed_date":"2016-04-08","scope":"insider"},{"id":8453658,"accession":"0001179110-15-014061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-014061","line_url":"/filing/0001179110-15-014061#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":23.93,"price_display":"23.93","price_state":"stated","total_value":57432.0,"total_display":"57,432.00","shares_owned_after":91604.0,"shares_owned_after_display":"91,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-15","filed_date":"2015-10-16","scope":"insider"},{"id":8453653,"accession":"0001179110-15-014061","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-014061","line_url":"/filing/0001179110-15-014061#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":22.66,"price_display":"22.66","price_state":"stated","total_value":54384.0,"total_display":"54,384.00","shares_owned_after":94004.0,"shares_owned_after_display":"94,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-15","filed_date":"2015-10-16","scope":"insider"},{"id":8453647,"accession":"0001179110-15-014061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-014061","line_url":"/filing/0001179110-15-014061#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":22.69,"price_display":"22.69","price_state":"stated","total_value":15883.0,"total_display":"15,883.00","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-10-15","filed_date":"2015-10-16","scope":"insider"},{"id":8453639,"accession":"0001179110-15-014061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-014061","line_url":"/filing/0001179110-15-014061#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":23.94,"price_display":"23.94","price_state":"stated","total_value":11970.0,"total_display":"11,970.00","shares_owned_after":8500.0,"shares_owned_after_display":"8,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-10-15","filed_date":"2015-10-16","scope":"insider"},{"id":8172813,"accession":"0001104659-15-066038","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-15-066038","line_url":"/filing/0001104659-15-066038#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":32.22,"price_display":"32.22","price_state":"stated","total_value":35442.0,"total_display":"35,442.00","shares_owned_after":96904.0,"shares_owned_after_display":"96,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-16","filed_date":"2015-09-18","scope":"insider"},{"id":8172811,"accession":"0001104659-15-066038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-15-066038","line_url":"/filing/0001104659-15-066038#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":34.96,"price_display":"34.96","price_state":"stated","total_value":13984.0,"total_display":"13,984.00","shares_owned_after":9700.0,"shares_owned_after_display":"9,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-09-16","filed_date":"2015-09-18","scope":"insider"},{"id":8172807,"accession":"0001104659-15-066038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-066038","line_url":"/filing/0001104659-15-066038#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":33.55,"price_display":"33.55","price_state":"stated","total_value":10065.0,"total_display":"10,065.00","shares_owned_after":96604.0,"shares_owned_after_display":"96,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-16","filed_date":"2015-09-18","scope":"insider"},{"id":8172804,"accession":"0001104659-15-066038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-066038","line_url":"/filing/0001104659-15-066038#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":34.93,"price_display":"34.93","price_state":"stated","total_value":6986.0,"total_display":"6,986.00","shares_owned_after":96404.0,"shares_owned_after_display":"96,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-16","filed_date":"2015-09-18","scope":"insider"},{"id":8862975,"accession":"0001179110-15-012360","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-15-012360","line_url":"/filing/0001179110-15-012360#line-9","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2790.0,"shares_display":"2,790","price_per_share":30.83,"price_display":"30.83","price_state":"stated","total_value":86015.7,"total_display":"86,015.70","shares_owned_after":33214.0,"shares_owned_after_display":"33,214","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8862973,"accession":"0001179110-15-012360","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-15-012360","line_url":"/filing/0001179110-15-012360#line-8","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":31.0,"price_display":"31.00","price_state":"stated","total_value":43400.0,"total_display":"43,400.00","shares_owned_after":32204.0,"shares_owned_after_display":"32,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8862971,"accession":"0001179110-15-012360","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-15-012360","line_url":"/filing/0001179110-15-012360#line-7","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1210.0,"shares_display":"1,210","price_per_share":31.6,"price_display":"31.60","price_state":"stated","total_value":38236.0,"total_display":"38,236.00","shares_owned_after":32004.0,"shares_owned_after_display":"32,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8862969,"accession":"0001179110-15-012360","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-15-012360","line_url":"/filing/0001179110-15-012360#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":30.99,"price_display":"30.99","price_state":"stated","total_value":24792.0,"total_display":"24,792.00","shares_owned_after":10300.0,"shares_owned_after_display":"10,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8862967,"accession":"0001179110-15-012360","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-15-012360","line_url":"/filing/0001179110-15-012360#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":31.95,"price_display":"31.95","price_state":"stated","total_value":12780.0,"total_display":"12,780.00","shares_owned_after":11100.0,"shares_owned_after_display":"11,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8862965,"accession":"0001179110-15-012360","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-012360","line_url":"/filing/0001179110-15-012360#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.69,"price_display":"31.69","price_state":"stated","total_value":6338.0,"total_display":"6,338.00","shares_owned_after":32004.0,"shares_owned_after_display":"32,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8862963,"accession":"0001179110-15-012360","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-012360","line_url":"/filing/0001179110-15-012360#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":31.69,"price_display":"31.69","price_state":"stated","total_value":6338.0,"total_display":"6,338.00","shares_owned_after":10100.0,"shares_owned_after_display":"10,100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-19","scope":"insider"},{"id":8862852,"accession":"0001179110-15-011391","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-15-011391","line_url":"/filing/0001179110-15-011391#line-7","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":32.29,"price_display":"32.29","price_state":"stated","total_value":125931.0,"total_display":"125,931.00","shares_owned_after":32104.0,"shares_owned_after_display":"32,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-20","filed_date":"2015-07-21","scope":"insider"},{"id":8862850,"accession":"0001179110-15-011391","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-15-011391","line_url":"/filing/0001179110-15-011391#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":32.31,"price_display":"32.31","price_state":"stated","total_value":32310.0,"total_display":"32,310.00","shares_owned_after":11700.0,"shares_owned_after_display":"11,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-20","filed_date":"2015-07-21","scope":"insider"},{"id":8862848,"accession":"0001179110-15-011391","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-15-011391","line_url":"/filing/0001179110-15-011391#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":33.22,"price_display":"33.22","price_state":"stated","total_value":26576.0,"total_display":"26,576.00","shares_owned_after":32004.0,"shares_owned_after_display":"32,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-20","filed_date":"2015-07-21","scope":"insider"},{"id":8862846,"accession":"0001179110-15-011391","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-011391","line_url":"/filing/0001179110-15-011391#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":33.22,"price_display":"33.22","price_state":"stated","total_value":6644.0,"total_display":"6,644.00","shares_owned_after":11500.0,"shares_owned_after_display":"11,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-20","filed_date":"2015-07-21","scope":"insider"},{"id":8862844,"accession":"0001179110-15-011391","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-011391","line_url":"/filing/0001179110-15-011391#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":32.74,"price_display":"32.74","price_state":"stated","total_value":3274.0,"total_display":"3,274.00","shares_owned_after":32004.0,"shares_owned_after_display":"32,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-20","filed_date":"2015-07-21","scope":"insider"},{"id":8782271,"accession":"0001179110-15-010052","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-15-010052","line_url":"/filing/0001179110-15-010052#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001325710","owner_name":"Sherman Matthew L","owner_url":"/insider/0001325710","role":"Officer (EVP & Chief Medical Officer)","officer_title":"EVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5600.0,"shares_display":"5,600","price_per_share":31.57,"price_display":"31.57","price_state":"stated","total_value":176792.0,"total_display":"176,792.00","shares_owned_after":32004.0,"shares_owned_after_display":"32,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-18","filed_date":"2015-06-19","scope":"insider"}],"next_cursor":"2015-06-18|8782271","ledger_fault":false,"count":{"value":126,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":125,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":126},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001654151","name":"Deciphera Pharmaceuticals, Inc.","url":"/issuer/0001654151","role":"Officer (EVP & Chief Medical Officer)","n_filings":13,"first_seen":"2021-02-18","last_seen":"2024-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001574235","name":"Pulmatrix, Inc.","url":"/issuer/0001574235","role":"Director","n_filings":1,"first_seen":"2018-04-05","last_seen":"2018-04-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Officer (EVP & Chief Medical Officer)","n_filings":35,"first_seen":"2014-04-24","last_seen":"2018-04-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001325710","retrieved_at":"2026-08-22T04:33:31+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}